165 related articles for article (PubMed ID: 8406818)
1. Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern.
de Boer JP; Creasey AA; Chang A; Roem D; Eerenberg AJ; Hack CE; Taylor FB
Infect Immun; 1993 Oct; 61(10):4293-301. PubMed ID: 8406818
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase.
Jansen PM; Pixley RA; Brouwer M; de Jong IW; Chang AC; Hack CE; Taylor FB; Colman RW
Blood; 1996 Mar; 87(6):2337-44. PubMed ID: 8630396
[TBL] [Abstract][Full Text] [Related]
3. C4b-binding protein exacerbates the host response to Escherichia coli.
Taylor F; Chang A; Ferrell G; Mather T; Catlett R; Blick K; Esmon CT
Blood; 1991 Jul; 78(2):357-63. PubMed ID: 1829967
[TBL] [Abstract][Full Text] [Related]
4. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock.
Jansen PM; Eisele B; de Jong IW; Chang A; Delvos U; Taylor FB; Hack CE
J Immunol; 1998 Jan; 160(1):475-84. PubMed ID: 9552006
[TBL] [Abstract][Full Text] [Related]
5. Complement and leukocyte activation in septic baboons.
Bengtsson A; Redl H; Paul E; Schlag G; Mollnes TE; Davies J
Circ Shock; 1993 Feb; 39(2):83-8. PubMed ID: 8490996
[TBL] [Abstract][Full Text] [Related]
6. Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model.
de Boer JP; Creasey AA; Chang A; Abbink JJ; Roem D; Eerenberg AJ; Hack CE; Taylor FB
Infect Immun; 1993 Dec; 61(12):5035-43. PubMed ID: 7693593
[TBL] [Abstract][Full Text] [Related]
7. Anti-TNF treatment of baboons with sepsis reduces TNF-alpha, IL-6 and IL-8, but not the degree of complement activation.
Bengtsson A; Redl H; Schlag G; Högåsen K; Götze O; Mollnes TE
Scand J Immunol; 1998 Nov; 48(5):509-14. PubMed ID: 9822260
[TBL] [Abstract][Full Text] [Related]
8. Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli.
de Boer JP; Creasy AA; Chang A; Roem D; Brouwer MC; Eerenberg AJ; Hack CE; Taylor FB
Circ Shock; 1993 Jan; 39(1):59-67. PubMed ID: 7683256
[TBL] [Abstract][Full Text] [Related]
9. Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants.
Taylor FB
Crit Care Med; 2001 Jul; 29(7 Suppl):S78-89. PubMed ID: 11445739
[TBL] [Abstract][Full Text] [Related]
10. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.
Barilla-LaBarca ML; Liszewski MK; Lambris JD; Hourcade D; Atkinson JP
J Immunol; 2002 Jun; 168(12):6298-304. PubMed ID: 12055245
[TBL] [Abstract][Full Text] [Related]
11. Effects on complement activation and cytokine (TNF-alpha and IL-8) release of infusion of anti-TNF-antibodies or a xanthine derivative (HWA 138) in septic baboons.
Bengtsson A; Redl H; Schlag G; Mollnes TE; Högåsen K
Acta Anaesthesiol Scand; 1996 Feb; 40(2):244-9. PubMed ID: 8848926
[TBL] [Abstract][Full Text] [Related]
12. Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation.
Wooster DG; Maruvada R; Blom AM; Prasadarao NV
Immunology; 2006 Apr; 117(4):482-93. PubMed ID: 16556262
[TBL] [Abstract][Full Text] [Related]
13. A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b.
Meri S; Pangburn MK
Eur J Immunol; 1990 Dec; 20(12):2555-61. PubMed ID: 2148521
[TBL] [Abstract][Full Text] [Related]
14. Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC).
Mollnes TE; Redl H; Høgåsen K; Bengtsson A; Garred P; Speilberg L; Lea T; Oppermann M; Götze O; Schlag G
Clin Exp Immunol; 1993 Feb; 91(2):295-300. PubMed ID: 7679061
[TBL] [Abstract][Full Text] [Related]
15. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
Ziccardi RJ
J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
[TBL] [Abstract][Full Text] [Related]
16. Effects of anti-C5a monoclonal antibodies on oxygen use in a porcine model of severe sepsis.
Mohr M; Höpken U; Oppermann M; Mathes C; Goldmann K; Siever S; Götze O; Burchardi H
Eur J Clin Invest; 1998 Mar; 28(3):227-34. PubMed ID: 9568469
[TBL] [Abstract][Full Text] [Related]
17. Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma.
Jansen PM; van der Pouw Kraan TC; de Jong IW; van Mierlo G; Wijdenes J; Chang AA; Aarden LA; Taylor FB; Hack CE
Blood; 1996 Jun; 87(12):5144-51. PubMed ID: 8652827
[TBL] [Abstract][Full Text] [Related]
18. Complement inhibition decreases early fibrogenic events in the lung of septic baboons.
Silasi-Mansat R; Zhu H; Georgescu C; Popescu N; Keshari RS; Peer G; Lupu C; Taylor FB; Pereira HA; Kinasewitz G; Lambris JD; Lupu F
J Cell Mol Med; 2015 Nov; 19(11):2549-63. PubMed ID: 26337158
[TBL] [Abstract][Full Text] [Related]
19. Monocyte chemotactic protein 1 is released during lethal and sublethal bacteremia in baboons.
Jansen PM; van Damme J; Put W; de Jong IW; Taylor FB; Hack CE
J Infect Dis; 1995 Jun; 171(6):1640-2. PubMed ID: 7769308
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
